Clicky

Saturday, October 31, 2026

Companies

Public company updates

CFO Thomassin Laurent Reports Share Transactions for Wise Group

Thomassin Laurent, CFO of Wise Group plc, reports share transactions, acquiring and selling shares as part of tax obligations. Details in SEC filing.

Volpe Sandra M acquires Restricted Stock Units from Republic Services

Volpe Sandra M acquires Restricted Stock Units from Republic Services, signaling ongoing executive investment in the refuse systems industry.

Flower Johanna Reports Significant Share Sales in CrowdStrike

Flower Johanna discloses multiple stock sales in CrowdStrike Holdings, indicating strategic financial maneuvers that may affect investor sentiment.

Snee James P reports Restricted Stock Units transaction

Snee James P disclosed a transaction involving Restricted Stock Units, highlighting executive compensation trends at Republic Services, Inc.

Iambic Therapeutics CFO Secora Acquires 61,342 Shares

Iambic Therapeutics CFO Michael Secora acquires 61,342 shares in a recent transaction, reflecting the company's ongoing activities in the biological products sector.

Duffy Michael A acquires Restricted Stock Units in filing

Duffy Michael A reports acquisition of Restricted Stock Units, reflecting ongoing compensation strategies within the refuse systems industry.

Kadre Manuel Acquires Restricted Stock Units in Republic Services

Kadre Manuel acquires 117.47 restricted stock units in Republic Services, signaling confidence in the company's future.

Michael Larson acquires restricted stock units from Republic Services

Michael Larson acquires 115.64 restricted stock units from Republic Services, signaling ongoing commitment and reflecting trends in executive compensation.

Bowie James Ulrich acquires 10,000 stock options at Exozyme

Bowie James Ulrich reports acquiring 10,000 stock options in Exozyme, reflecting confidence in the company's future and potentially influencing the biological products sector.

Rubin Shmuel Reports Equity Compensation Change in SEC Filing

Rubin Shmuel's SEC filing details a new equity compensation program aimed at aligning executive pay with long-term growth and shareholder value.

EXOZYMES INC. Reports Stock Option Transaction by Director

EXOZYMES INC. discloses a stock option transaction by director Christopher Marlett, indicating ongoing activity in the biological products sector.

Craig Ian M. Acquires Restricted Stock Units at Republic Services

Craig Ian M. acquires restricted stock units, reflecting ongoing compensation strategies at Republic Services. Industry implications may follow.

Flower Johanna Amends Filing for Restricted Stock Units

Flower Johanna corrects a filing related to restricted stock units, emphasizing the importance of accurate financial disclosures in the software services industry.

BillionToOne's Thomas Lynch Acquires 2,000 Shares

BillionToOne, Inc. reports stock acquisition by officer Thomas Lynch, signaling confidence in the company's growth within the medical laboratories sector.

Harris Ronan sells shares to cover tax obligations

Harris Ronan, CCO of Snap Inc, sold shares to cover tax obligations related to restricted stock units, reflecting ongoing trends in executive stock management.

Vogelstein R Jacob acquires nearly 2 million shares of IAM

Vogelstein R Jacob reports acquisition of nearly 2 million shares of Iambic Therapeutics, signaling potential confidence in the company.

Jeffrey McCall acquires 1,791 shares of Tejon Ranch Co.

Jeffrey McCall has acquired 1,791 shares of Tejon Ranch Co., increasing his ownership stake to 13,089 shares, as reported in a recent SEC filing.

EXOZYMES INC. Reports Stock Option Grant for Director

EXOZYMES INC. files a report detailing a stock option grant for director Anthony DiGiandomenico, emphasizing ongoing personnel incentives.

Oracle CEO Sicilia acquires 446,197 restricted stock units

Michael D. Sicilia, CEO of Oracle Corp, acquires 446,197 restricted stock units, reflecting a strategic move in executive compensation.

Iambic Therapeutics Chairperson Reports Major Stock Transactions

Iambic Therapeutics' Chairperson William H. Rastetter reports significant stock transactions, indicating strategic moves within the company.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →